Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin

2.50
Hdl Handle:
http://hdl.handle.net/10757/620710
Title:
Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
Authors:
Gomes, Cláudia ( 0000-0003-3746-1671 ) ; Martínez Puchol, Sandra ( 0000-0002-7549- 9614 ) ; Palma, Noemí; Horna, Gertrudis ( 0000-0001-8974-7044 ) ; Ruiz-Roldán, Lidia; Pons, Maria J ( 0000-0001-8384-2315 ) ; Ruiz, Joaquim ( 0000-0002-4431-2036 )
Citation:
1. Gomes C, Martínez-puchol S, Palma N, Horna G, Ruiz-roldán L, Pons MJ, et al. Critical Reviews in Microbiology Macrolide resistance mechanisms in Enterobacteriaceae : Focus on azithromycin Macrolide resistance mechanisms in Enterobacteriaceae : Focus on azithromycin. Crit Rev Microbiol [Internet]. Informa Healthcare USA, Inc; 2016;0(0):000. Available from: http://dx.doi.org/10.3109/1040841X.2015.1136261
Publisher:
Taylor & Francis
Journal:
Critical Reviews in Microbiology
Issue Date:
27-Oct-2016
URI:
http://hdl.handle.net/10757/620710
DOI:
10.3109/1040841X.2015.1136261
Additional Links:
https://www.tandfonline.com/doi/full/10.3109/1040841X.2015.1136261
Abstract:
From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Grampositive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.
Type:
info:eu-repo/semantics/article
Rights:
info:eu-repo/semantics/openAccess
Language:
eng
Keywords:
23S rRNA; Methylases; Esterases; Phospotransferases;; Ribosomal mutations
ISSN:
1040-841X; 1549-7828
Sponsors:
CG has a PhD fellowship of the ISCIII [grant number: FI12/ 00561]. GH has a PhD fellowship from the Schlumberger Foundation – Faculty for The Future Program. LR-R has a PhD fellowship from Sistema Riojano de Innovaci on del Gobierno de La Rioja. MJP has a postdoctoral fellowship from CONCYTEC [grant number: CG05-2013-FONDECYT]. JR has a fellowship from the program I3, of the ISCIII [grant number: CES11/012]. The study was supported by the Generalitat de Catalunya, Departament d’Universitats, Recerca i Societat de la Informaci o [2014 SGR 26] and by the Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015].
Email:
joruiz.trabajo@gmail.com

Full metadata record

DC FieldValue Language
dc.contributor.authorGomes, Cláudiaes_PE
dc.contributor.authorMartínez Puchol, Sandraes_PE
dc.contributor.authorPalma, Noemíes_PE
dc.contributor.authorHorna, Gertrudises_PE
dc.contributor.authorRuiz-Roldán, Lidiaes_PE
dc.contributor.authorPons, Maria Jes_PE
dc.contributor.authorRuiz, Joaquimes_PE
dc.date.accessioned2016-10-28T23:33:20Z-
dc.date.available2016-10-28T23:33:20Z-
dc.date.issued2016-10-27-
dc.identifier.citation1. Gomes C, Martínez-puchol S, Palma N, Horna G, Ruiz-roldán L, Pons MJ, et al. Critical Reviews in Microbiology Macrolide resistance mechanisms in Enterobacteriaceae : Focus on azithromycin Macrolide resistance mechanisms in Enterobacteriaceae : Focus on azithromycin. Crit Rev Microbiol [Internet]. Informa Healthcare USA, Inc; 2016;0(0):000. Available from: http://dx.doi.org/10.3109/1040841X.2015.1136261es_PE
dc.identifier.issn1040-841X-
dc.identifier.issn1549-7828-
dc.identifier.doi10.3109/1040841X.2015.1136261-
dc.identifier.urihttp://hdl.handle.net/10757/620710es_PE
dc.description.abstractFrom its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Grampositive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.es_PE
dc.description.sponsorshipCG has a PhD fellowship of the ISCIII [grant number: FI12/ 00561]. GH has a PhD fellowship from the Schlumberger Foundation – Faculty for The Future Program. LR-R has a PhD fellowship from Sistema Riojano de Innovaci on del Gobierno de La Rioja. MJP has a postdoctoral fellowship from CONCYTEC [grant number: CG05-2013-FONDECYT]. JR has a fellowship from the program I3, of the ISCIII [grant number: CES11/012]. The study was supported by the Generalitat de Catalunya, Departament d’Universitats, Recerca i Societat de la Informaci o [2014 SGR 26] and by the Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015].es_PE
dc.formatapplication/pdfes_PE
dc.language.isoenges_PE
dc.publisherTaylor & Francises_PE
dc.relation.urlhttps://www.tandfonline.com/doi/full/10.3109/1040841X.2015.1136261es_PE
dc.rightsinfo:eu-repo/semantics/openAccesses_PE
dc.sourceUniversidad Peruana de Ciencias Aplicadas (UPC)es_PE
dc.sourceRepositorio Académico - UPCes_PE
dc.subject23S rRNAes_PE
dc.subjectMethylaseses_PE
dc.subjectEsteraseses_PE
dc.subjectPhospotransferases;es_PE
dc.subjectRibosomal mutationses_PE
dc.titleMacrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycines_PE
dc.typeinfo:eu-repo/semantics/articlees_PE
dc.identifier.journalCritical Reviews in Microbiologyes_PE
dc.description.peerreviewRevisión por pareses_PE
dc.contributor.emailjoruiz.trabajo@gmail.comes_PE
All Items in UPC are protected by copyright, with all rights reserved, unless otherwise indicated.